Assessing the quality of life of patients in cancer clinical trials: Common problems and common sense solutions
- 31 December 1992
- journal article
- editorial
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (8-9) , 1304-1307
- https://doi.org/10.1016/0959-8049(92)90504-u
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trialEuropean Journal Of Cancer, 1992
- The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review.Journal of Clinical Oncology, 1991
- The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Methodologic issues in assessing the quality of life of cancer patientsCancer, 1991
- Quality of life and treatment of hormone resistant metastatic prostatic cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Quality of Life End Points in Cancer Clinical Trials: Review and RecommendationsJNCI Journal of the National Cancer Institute, 1989
- Barriers to the Use of Health Status Measures in Clinical Investigation, Patient Care, and Policy ResearchMedical Care, 1989
- A Pilot Study of the Functional Living Index-Cancer (FLIC) Scale for the Assessment of Quality of Life for Metastatic Lung Cancer PatientsAmerican Journal of Clinical Oncology, 1988
- Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the functional living index—cancerCancer, 1988
- Improving the Quality of Life during Chemotherapy for Advanced Breast CancerNew England Journal of Medicine, 1987